MISSION Therapeutics

MISSION Therapeutics is a specialist pharmaceutical company whose aim is to translate new molecular understandings of human cell biology into drugs that will markedly improve the management of life-threatening diseases, particularly cancer.

Total money raised: $10M

CB22 3AT Meditrina (Building 260)
Babraham Reseach Campus

Updated on Aug 25, 2011
MISSION Therapeutics at CrunchBase
Deborah Harland Non Executive Director

August, 2011

MISSION Therapeutics raised $10M in unattributed round from Imperial Innovations, Sofinnova Partners, SR One, and Roche Venture Fund

MissionTherapeutics Ltd Raises $10 Million, Eyes Rapid Growth